CBHD.DE

Coloplast A/S [CBHD.DE] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

CBHD.DE Stock Summary

Top 10 Correlated ETFs

CBHD.DE


Top 10 Correlated Stocks

CBHD.DE


In the News

CBHD.DE Financial details

Company Rating
Strong Buy
Market Cap
27.75B
Income
4.87B
Revenue
25.05B
Book val./share
69.22
Cash/share
4.19
Dividend
21
Dividend %
2.69%
Employees
15.75K
Optionable
No
Shortable
Yes
Earnings
07 May 2024
P/E
36.7
Forward P/E
4.45
PEG
94.48
P/S
7.18
P/B
10.15
P/C
29.58
P/FCF
48.2
Quick Ratio
0.06
Current Ratio
0.61
Debt / Equity
1.43
LT Debt / Equity
0.81
-
-
EPS (TTM)
23
EPS next Y
27.84
EPS next Q
5.8
EPS this Y
0.32%
EPS next Y
21.03%
EPS next 5Y
82.77%
EPS last 5Y
4.02%
Revenue last 5Y
6.43%
Revenue Q/Q
6.1%
EPS Q/Q
-4.26%
-
-
-
-
SMA20
2.46%
SMA50
16.82%
SMA100
23.76%
Inst Own
0.01%
Inst Trans
1%
ROA
10%
ROE
51%
ROC
0.21%
Gross Margin
66%
Oper. Margin
27%
Profit Margin
20%
Payout
111%
Shs Outstand
222.29M
Shs Float
152.31M
-
-
-
-
Target Price
-
52W Range
92.5-132.75
52W High
-6.1%
52W Low
+34.73%
RSI
54
Rel Volume
0.04
Avg Volume
475
Volume
18
Perf Week
0.85%
Perf Month
4.42%
Perf Quarter
25.1%
Perf Half Y
22.78%
-
-
-
-
Beta
0.292
-
-
Volatility
0.67%, 3.06%
Prev Close
-1.39%
Price
123.95
Change
-0.88%

CBHD.DE Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-09-30

Metric History 2019-09-302020-09-302021-09-302022-09-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
84.587.2291.29106.25113.74
Net income per share
18.2419.7422.6722.1522.21
Operating cash flow per share
20.5222.3824.862419.62
Free cash flow per share
17.5318.0115.6218.6513.86
Cash per share
3.152.753.172.984.23
Book value per share
32.5634.8438.3839.0280.31
Tangible book value per share
20.7823.7221.23-56.4-64.79
Share holders equity per share
32.5634.8438.3839.0280.31
Interest debt per share
5.728.3613.2188.8593.8
Market cap
175.94B216.29B217.67B164.1B161.44B
Enterprise value
176.79B217.72B220.01B182.39B180.09B
P/E ratio
45.4351.5445.1134.8733.75
Price to sales ratio
9.8111.6611.217.276.59
POCF ratio
40.3845.4541.1532.1838.2
PFCF ratio
47.2856.565.4841.454.08
P/B Ratio
25.4529.2126.6519.799.33
PTB ratio
25.4529.2126.6519.799.33
EV to sales
9.8611.7411.338.087.35
Enterprise value over EBITDA
28.4633.7930.4223.1923.3
EV to operating cash flow
40.5845.7541.5935.7742.62
EV to free cash flow
47.5156.8766.1946.0160.33
Earnings yield
0.020.020.020.030.03
Free cash flow yield
0.020.020.020.020.02
Debt to equity
0.170.240.342.261.13
Debt to assets
0.090.130.180.540.41
Net debt to EBITDA
0.140.220.322.332.41
Current ratio
1.291.31.111.20.61
Interest coverage
859.33195.13254.237.4410.61
Income quality
0.850.810.860.790.62
Dividend Yield
0.020.020.020.020.03
Payout ratio
0.880.860.790.860.89
Sales general and administrative to revenue
0.040.040.040.040.05
Research and developement to revenue
0.040.040.040.040.04
Intangibles to total assets
0.20.180.230.580.65
Capex to operating cash flow
-0.15-0.2-0.37-0.22-0.29
Capex to revenue
-0.04-0.05-0.1-0.05-0.05
Capex to depreciation
-0.98-1.09-2.48-1.22-1.16
Stock based compensation to revenue
00000
Graham number
115.61124.39139.93139.44200.31
ROIC
0.480.460.420.180.14
Return on tangible assets
0.380.380.40.320.28
Graham Net
-8.57-10.32-15.86-101.09-115.84
Working capital
1.42B1.51B680M1.44B-6.37B
Tangible asset value
4.41B5.04B4.52B-11.99B-13.96B
Net current asset value
540M396M-679M-17.89B-20.92B
Invested capital
0.170.240.342.261.13
Average receivables
1.58B3.04B3.07B3.58B4.13B
Average payables
805M836.5M925M1.14B1.27B
Average inventory
1.83B2.08B2.33B2.81B3.35B
Days sales outstanding
64.1557.7560.3563.6964.28
Days payables outstanding
54.1950.0961.8664.357.8
Days of inventory on hand
121.94137.03144.97165157.31
Receivables turnover
5.696.326.055.735.68
Payables turnover
6.747.295.95.686.32
Inventory turnover
2.992.662.522.212.32
ROE
0.560.570.590.570.28
Capex per share
-3-4.38-9.24-5.34-5.76

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q1

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
28.5428.7628.7628.5130.23
Net income per share
5.315.445.995.635.55
Operating cash flow per share
3.245.55.58.618.18
Free cash flow per share
1.874.134.136.856.92
Cash per share
3.034.14.034.174.19
Book value per share
33.1230.5630.5679.2169.22
Tangible book value per share
-59.18-58.22-58.22-63.9-74.67
Share holders equity per share
33.1230.5630.5679.2169.22
Interest debt per share
103.01104.78104.7890.4599.79
Market cap
173.91B192.53B182.53B163.69B169.46B
Enterprise value
194.93B213.79B203.79B182.34B190.18B
P/E ratio
38.5841.6735.8733.334.96
Price to sales ratio
28.6931.5229.8826.2925.65
POCF ratio
252.42164.7156.1487.0294.78
PFCF ratio
436.97219.28207.89109.34112.08
P/B Ratio
24.7229.6728.129.4611.2
PTB ratio
24.7229.6728.129.4611.2
EV to sales
32.163533.3629.2928.79
Enterprise value over EBITDA
98.4107.65102.6190.9995.47
EV to operating cash flow
282.92182.88174.3396.94106.36
EV to free cash flow
489.79243.5232.1121.81125.78
Earnings yield
0.010.010.010.010.01
Free cash flow yield
0000.010.01
Debt to equity
3.083.413.411.131.43
Debt to assets
0.610.630.630.410.45
Net debt to EBITDA
10.6110.710.79.3110.4
Current ratio
0.990.980.980.610.53
Interest coverage
7.1212.1612.168.810.47
Income quality
0.420.680.681.140.99
Dividend Yield
0.020.010.0100.02
Payout ratio
2.830.920.8302.97
Sales general and administrative to revenue
0.050.040.040.040.05
Research and developement to revenue
0.030.040.040.040.04
Intangibles to total assets
0.560.540.540.650.65
Capex to operating cash flow
-0.42-0.25-0.25-0.2-0.15
Capex to revenue
-0.05-0.05-0.05-0.06-0.04
Capex to depreciation
-1.09-1.11-1.11-1.39-0.9
Stock based compensation to revenue
0000.010
Graham number
62.8861.1464.17100.1492.95
ROIC
0.040.050.050.040.04
Return on tangible assets
0.070.070.080.070.07
Graham Net
-107.83-108.08-107.86-114.25-125.84
Working capital
-110M-165M-165M-6.37B-8.85B
Tangible asset value
-12.57B-12.37B-12.37B-13.96B-16.32B
Net current asset value
-18.95B-18.92B-18.92B-20.92B-23.4B
Invested capital
3.083.413.411.131.43
Average receivables
3.95B3.97B4.03B4.19B4.35B
Average payables
1.05B1.1B1.07B1.18B1.23B
Average inventory
3.45B3.53B3.56B3.54B3.52B
Days sales outstanding
58.758.766062.3859.84
Days payables outstanding
50.2746.1946.1955.6249.75
Days of inventory on hand
155.4153.54153.54151.38150.67
Receivables turnover
1.531.531.51.441.5
Payables turnover
1.791.951.951.621.81
Inventory turnover
0.580.590.590.590.6
ROE
0.160.180.20.070.08
Capex per share
-1.37-1.37-1.37-1.76-1.26

CBHD.DE Frequently Asked Questions

What is Coloplast A/S stock symbol ?

Coloplast A/S is a DK stock and trading under the symbol CBHD.DE

What is Coloplast A/S stock quote today ?

Coloplast A/S stock price is $123.95 today.

Is Coloplast A/S stock public?

Yes, Coloplast A/S is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap